CID HoldCo, Inc.
Key Metrics
Market Snapshot
About
CID HoldCo, Inc., formerly CIIG Capital Partners II, Inc., is a company that completed its business combination with Sera Prognostics in 2021. The combined entity focuses on developing and commercializing innovative biomarker tests to improve pregnancy outcomes. The company's flagship product is the PreTRM test, designed to predict the risk of premature birth in pregnant women. CID HoldCo operates in the women's health diagnostics market, utilizing proteomics technology to address critical maternal and fetal health challenges.